Genmab As Stock Performance

Genmab A/S Relative Risk vs. Return Landscape

If you would invest  30,500  in Genmab AS on November 17, 2025 and sell it today you would lose (500.00) from holding Genmab AS or give up 1.64% of portfolio value over 90 days. Genmab AS is currently producing negative expected returns and takes up 2.0295% volatility of returns over 90 trading days. Put another way, 18% of traded pink sheets are less volatile than Genmab, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days.Assuming the 90 days horizon Genmab A/S is expected to under-perform the market. In addition to that, the company is 2.66 times more volatile than its market benchmark. It trades about 0.0 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.13 per unit of volatility.

Genmab A/S Target Price Odds to finish over Current Price

Assuming the 90 days horizon Genmab A/S has a beta of 0.26. This usually indicates as returns on the market go up, Genmab A/S average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Genmab AS will be expected to be much smaller as well. Additionally Genmab AS has an alpha of 0.0439, implying that it can generate a 0.0439 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).

Predictive Modules for Genmab A/S

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Genmab A/S. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.

Hype Prediction Low Estimated High 297.97 300.00 302.03 Details

Intrinsic Valuation Low Real High 260.89 262.92 330.00 Details

Genmab A/S Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Genmab A/S is not an exception. The market had few large corrections towards the Genmab A/S's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Genmab AS, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Genmab A/S within the framework of very fundamental risk indicators.

Genmab A/S Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Genmab A/S for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Genmab A/S can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.

Genmab A/S Fundamentals Growth

When running Genmab A/S's price analysis, check to measure Genmab A/S's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genmab A/S is operating at the current time. Most of Genmab A/S's value examination focuses on studying past and present price action to predict the probability of Genmab A/S's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genmab A/S's price. Additionally, you may evaluate how the addition of Genmab A/S to your portfolios can decrease your overall portfolio volatility.